Adicet Bio, Inc.
ACET
$0.6736
$0.00260.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.63% | 5.15% | 5.00% | 3.38% | 0.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.74% | -3.12% | 4.34% | 17.68% | 35.92% |
| Operating Income | 3.74% | 3.12% | -4.34% | -17.68% | -82.74% |
| Income Before Tax | 17.90% | 17.59% | -19.22% | -32.77% | -104.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.90% | 17.59% | -19.22% | -32.77% | -104.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.90% | 17.59% | -19.22% | -32.77% | -104.41% |
| EBIT | 3.74% | 3.12% | -4.34% | -17.68% | -82.74% |
| EBITDA | 4.22% | 4.09% | -2.81% | -15.43% | -80.75% |
| EPS Basic | 59.75% | 49.12% | 6.94% | -16.92% | -96.17% |
| Normalized Basic EPS | 53.39% | 41.17% | 23.59% | 0.99% | -69.42% |
| EPS Diluted | 59.75% | 49.12% | 6.94% | -16.92% | -94.33% |
| Normalized Diluted EPS | 53.39% | 41.17% | 23.59% | 0.99% | -67.88% |
| Average Basic Shares Outstanding | 104.39% | 78.01% | 51.13% | 25.08% | 5.35% |
| Average Diluted Shares Outstanding | 104.39% | 78.01% | 51.13% | 25.08% | 1.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
